Integrum AB Series B (INTEG-B) - Total Liabilities

Latest as of March 2026: Skr31.59 Million SEK ≈ $3.40 Million USD

Based on the latest financial reports, Integrum AB Series B (INTEG-B) has total liabilities worth Skr31.59 Million SEK (≈ $3.40 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore how fast is Integrum AB Series B growing its equity to track the company's year-over-year net asset growth rate.

Integrum AB Series B - Total Liabilities Trend (2013–2025)

This chart illustrates how Integrum AB Series B's total liabilities have evolved over time, based on quarterly financial data. See INTEG-B free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Integrum AB Series B Competitors by Total Liabilities

The table below lists competitors of Integrum AB Series B ranked by their total liabilities.

Company	Country	Total Liabilities
AVTECH Sweden AB Series B ST:AVT-B	Sweden	Skr5.20 Million
Bangkok Sheet Metal Public Company Limited BK:BM	Thailand	฿796.76 Million
Tevogen Bio Holdings Inc. NASDAQ:TVGN	USA	$14.76 Million
CHAR Technologies Ltd V:YES	Canada	CA$3.99 Million
Handok Clean Tech Co. Ltd KQ:256150	Korea	₩10.17 Billion
Juggernaut Exploration Ltd V:JUGR	Canada	CA$4.43 Million
Pili International Multimedia Co Ltd TWO:8450	Taiwan	NT$669.29 Million
OCB Bhd KLSE:5533	Malaysia	RM87.95 Million

Liability Composition Analysis (2013–2025)

This chart breaks down Integrum AB Series B's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Integrum AB Series B market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.77	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.18	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.16	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Integrum AB Series B's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Integrum AB Series B (2013–2025)

The table below shows the annual total liabilities of Integrum AB Series B from 2013 to 2025.

Year	Total Liabilities	Change
2025-12-31	Skr31.59 Million ≈ $3.40 Million	+24.48%
2024-12-31	Skr25.38 Million ≈ $2.73 Million	+14.98%
2023-12-31	Skr22.07 Million ≈ $2.38 Million	+2.01%
2022-12-31	Skr21.64 Million ≈ $2.33 Million	+4.55%
2021-12-31	Skr20.70 Million ≈ $2.23 Million	+60.25%
2020-12-31	Skr12.91 Million ≈ $1.39 Million	+52.49%
2019-12-31	Skr8.47 Million ≈ $911.38K	-4.33%
2018-12-31	Skr8.85 Million ≈ $952.60K	+5.65%
2017-12-31	Skr8.38 Million ≈ $901.62K	-9.31%
2016-12-31	Skr9.24 Million ≈ $994.23K	+2.27%
2015-12-31	Skr9.03 Million ≈ $972.20K	+71.03%
2014-12-31	Skr5.28 Million ≈ $568.43K	-5.99%
2013-12-31	Skr5.62 Million ≈ $604.66K	--

About Integrum AB Series B

ST:INTEG-B Sweden Medical Devices

Market Cap

$23.78 Million

Skr220.98 Million SEK

Market Cap Rank

#24499 Global

#488 in Sweden

Share Price

Skr8.49

Change (1 day)

-3.30%

52-Week Range

Skr6.96 - Skr43.10

All Time High

Skr102.00